Selected article for: "acute respiratory illness and molecular testing"
Author: Helen Y. Chu; Michael Boeckh; Janet A. Englund; Michael Famulare; Barry R. Lutz; Deborah A Nickerson; Mark J. Rieder; Lea M Starita; Amanda Adler; Elisabeth Brandstetter; Chris D. Frazar; Peter D. Han; Reena K. Gularti; James Hadfield; Michael L. Jackson; Anahita Kiavand; Louise E. Kimball; Kirsten Lacombe; Jennifer Logue; Victoria Lyon; Kira L. Newman; Thomas R. Sibley; Monica L. Zigman Suschsland; Caitlin Wolf; Jay Shendure; Trevor Bedford
Title: The Seattle Flu Study: a multi-arm community-based prospective study protocol for assessing influenza prevalence, transmission, and genomic epidemiology
  • Document date: 2020_3_6
    • ID: 4nmc356g_18
    Snippet: Study overview and setting In this study, participants are eligible if they have two or more acute respiratory illness (ARI)associated symptoms ( Table 1 ) or a medically-collected respiratory specimen. The presence of a subjective or objective fever is not required. All participants have a respiratory specimen collected that is linked with demographic information, illness characteristics, behavioral, and other clinical metadata. The primary outc.....
    Document: Study overview and setting In this study, participants are eligible if they have two or more acute respiratory illness (ARI)associated symptoms ( Table 1 ) or a medically-collected respiratory specimen. The presence of a subjective or objective fever is not required. All participants have a respiratory specimen collected that is linked with demographic information, illness characteristics, behavioral, and other clinical metadata. The primary outcome is influenza infection status as defined by molecular diagnostic testing. The study takes place during influenza season (October to May) annually, starting with 2018-2019.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory illness and respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory illness and study overview: 1
    • acute respiratory illness and study set: 1
    • demographic information and primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • demographic information and respiratory illness: 1, 2, 3, 4, 5, 6
    • demographic information and study overview: 1, 2, 3
    • demographic information and study set: 1, 2, 3, 4
    • diagnostic testing and primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • diagnostic testing and respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • diagnostic testing and study overview: 1
    • diagnostic testing and study set: 1
    • illness characteristic and respiratory illness: 1, 2, 3
    • influenza infection and primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza infection and respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza infection and study set: 1, 2, 3
    • influenza infection status and respiratory illness: 1, 2
    • influenza season and respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza season and study overview: 1
    • influenza season and study set: 1